PTN News

  • Project babyTAPE Measures Up January 14, 2016 On December 18, 10 days ahead of schedule, the PTN babyTAPE team enrolled its 2,000th participant. On January 29, the babyTAPE databse was locked. The data collected in the babyTAPE study will be used to develop, design, and validate a weight estimation tool, similar to what is pictured, specific to infants. The study is chaired by Dr. Susan ...
  • Timolol for Infantile Hemangiomas under Review November 17, 2015 Since first reported in 2008 that propranolol, a beta blocker, was effective in the treatment of Infantile Hemangiomas (IH)—a birthmark that most commonly appears as a rubbery, bright red nodule of extra blood vessels in the skin, commonly called a “strawberry”—this class of drug has been used as the first line of therapy for infants ...
  • PTN Pantoprazole Study Closes Enrollment September 22, 2015 Congratulations to the PTN Pantoprazole Study Team for closing enrollment with 41 subjects. The study goal was to enroll 40 subjects in two age groups. The dedicated team worked hard to keep the study on track and accomplish this goal. The Pantoprazole Study will evaluate the pharmacokinetics of pantoprazole in obese children and adolescents with gastroesophageal reflux ...
  • 2015 Best Pharmaceuticals for Children Act Update July 2, 2015 Dear Colleagues: We would like to thank you for your continued interest and past input into the Best Pharmaceuticals for Children Act (BPCA) program at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). As stakeholders in this important program, we would like to keep you abreast ...
  • PTN featured in the Wall Street Journal June 9, 2015 The Pediatric Trials made an appearance in the pages of the Wall Street Journal on June 8. Check out the story online: http://www.wsj.com/articles/how-much-of-a-drug-is-safe-for-preemies-1433784687.
  • PTN meropenem study published in the Federal Register May 28, 2015 The PTN marks another milestone as the Food and Drug Administration (FDA) has published a summary report of its pediatric study of meropenem in the Federal Register. Meropenem is a broad-spectrum anti-microbial drug often used to treat intra-abdominal infections in infants. The purpose of the PTN study, which began in the summer of 2008, was to ...
  • Mercy TAPE moves closer to market May 20, 2015 The FDA has approved the 510(k) application for the Mercy TAPE—an anthropometric-based device developed by Dr. Susan Abdel-Rahman at Children’s Mercy Hospital in Kansas City that predicts weight in children 2 months through 16 years of age. The results from the PTN study validating this device appeared in the Annals of Emergency Medicine in 2013. Section ...
  • PTN hosts an investigator gathering at PAS 2015 May 14, 2015 The PTN hosted an informational, informal gathering during the Pediatric Academic Society meeting in San Diego in late April, giving investigators and study personnel a chance to meet face to face. Thanks to all who participated!
  • PTN findings presented at PAS 2015 April 28, 2015 Check out the results from recent PTN studies presented at this year’s annual meeting of the Pediatric Academic Societies.
  • Meropenem label changed to reflect PTN findings March 24, 2015 The FDA recently changed the label for the drug meropenem to reflect findings from a study conducted by PTN investigators. Results from the study were published in the Pediatric Infectious Disease Journal.